137 related articles for article (PubMed ID: 11705773)
1. Functional properties of an agouti signaling protein variant and characteristics of its cognate radioligand.
Yang YK; Dickinson C; Lai YM; Li JY; Gantz I
Am J Physiol Regul Integr Comp Physiol; 2001 Dec; 281(6):R1877-86. PubMed ID: 11705773
[TBL] [Abstract][Full Text] [Related]
2. Effects of recombinant agouti-signaling protein on melanocortin action.
Yang YK; Ollmann MM; Wilson BD; Dickinson C; Yamada T; Barsh GS; Gantz I
Mol Endocrinol; 1997 Mar; 11(3):274-80. PubMed ID: 9058374
[TBL] [Abstract][Full Text] [Related]
3. Receptor-antagonist interactions in the complexes of agouti and agouti-related protein with human melanocortin 1 and 4 receptors.
Chai BX; Pogozheva ID; Lai YM; Li JY; Neubig RR; Mosberg HI; Gantz I
Biochemistry; 2005 Mar; 44(9):3418-31. PubMed ID: 15736952
[TBL] [Abstract][Full Text] [Related]
4. Agouti signaling protein inhibits melanogenesis and the response of human melanocytes to alpha-melanotropin.
Suzuki I; Tada A; Ollmann MM; Barsh GS; Im S; Lamoreux ML; Hearing VJ; Nordlund JJ; Abdel-Malek ZA
J Invest Dermatol; 1997 Jun; 108(6):838-42. PubMed ID: 9182807
[TBL] [Abstract][Full Text] [Related]
5. Inverse agonist activity of agouti and agouti-related protein.
Chai BX; Neubig RR; Millhauser GL; Thompson DA; Jackson PJ; Barsh GS; Dickinson CJ; Li JY; Lai YM; Gantz I
Peptides; 2003 Apr; 24(4):603-9. PubMed ID: 12860205
[TBL] [Abstract][Full Text] [Related]
6. Solid-phase peptide head-to-side chain cyclodimerization: discovery of C(2)-symmetric cyclic lactam hybrid α-melanocyte-stimulating hormone (MSH)/agouti-signaling protein (ASIP) analogues with potent activities at the human melanocortin receptors.
Mayorov AV; Cai M; Palmer ES; Liu Z; Cain JP; Vagner J; Trivedi D; Hruby VJ
Peptides; 2010 Oct; 31(10):1894-905. PubMed ID: 20688117
[TBL] [Abstract][Full Text] [Related]
7. Common requirements for melanocortin-4 receptor selectivity of structurally unrelated melanocortin agonist and endogenous antagonist, Agouti protein.
Oosterom J; Garner KM; den Dekker WK ; Nijenhuis WA; Gispen WH; Burbach JP; Barsh GS; Adan RA
J Biol Chem; 2001 Jan; 276(2):931-6. PubMed ID: 11024027
[TBL] [Abstract][Full Text] [Related]
8. Discovery of prototype peptidomimetic agonists at the human melanocortin receptors MC1R and MC4R.
Haskell-Luevano C; Hendrata S; North C; Sawyer TK; Hadley ME; Hruby VJ; Dickinson C; Gantz I
J Med Chem; 1997 Jul; 40(14):2133-9. PubMed ID: 9216831
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Agouti-related protein binding to melanocortin receptors.
Yang YK; Thompson DA; Dickinson CJ; Wilken J; Barsh GS; Kent SB; Gantz I
Mol Endocrinol; 1999 Jan; 13(1):148-55. PubMed ID: 9892020
[TBL] [Abstract][Full Text] [Related]
10. Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors.
Haskell-Luevano C; Nikiforovich G; Sharma SD; Yang YK; Dickinson C; Hruby VJ; Gantz I
J Med Chem; 1997 May; 40(11):1738-48. PubMed ID: 9171884
[TBL] [Abstract][Full Text] [Related]
11. Agouti structure and function: characterization of a potent alpha-melanocyte stimulating hormone receptor antagonist.
Willard DH; Bodnar W; Harris C; Kiefer L; Nichols JS; Blanchard S; Hoffman C; Moyer M; Burkhart W; Weiel J
Biochemistry; 1995 Sep; 34(38):12341-6. PubMed ID: 7547977
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity studies of the melanocortin peptides: discovery of potent and selective affinity antagonists for the hMC3 and hMC4 receptors.
Grieco P; Lavecchia A; Cai M; Trivedi D; Weinberg D; MacNeil T; Van der Ploeg LH; Hruby VJ
J Med Chem; 2002 Nov; 45(24):5287-94. PubMed ID: 12431055
[TBL] [Abstract][Full Text] [Related]
13. hMRAPa increases αMSH-induced hMC1R and hMC3R functional coupling and hMC4R constitutive activity.
Kay EI; Botha R; Montgomery JM; Mountjoy KG
J Mol Endocrinol; 2013 Apr; 50(2):203-15. PubMed ID: 23296982
[TBL] [Abstract][Full Text] [Related]
14. Agouti antagonism of melanocortin-4 receptor: greater effect with desacetyl-alpha-melanocyte-stimulating hormone (MSH) than with alpha-MSH.
Mountjoy KG; Willard DH; Wilkison WO
Endocrinology; 1999 May; 140(5):2167-72. PubMed ID: 10218968
[TBL] [Abstract][Full Text] [Related]
15. Antagonist and agonist activities of the mouse agouti protein fragment (91-131) at the melanocortin-1 receptor.
Eberle AN; Bódi J; Orosz G; Süli-Vargha H; Jäggin V; Zumsteg U
J Recept Signal Transduct Res; 2001 Feb; 21(1):25-45. PubMed ID: 11693171
[TBL] [Abstract][Full Text] [Related]
16. Molecular determination of agouti-related protein binding to human melanocortin-4 receptor.
Yang Y; Chen M; Lai Y; Gantz I; Yagmurlu A; Georgeson KE; Harmon CM
Mol Pharmacol; 2003 Jul; 64(1):94-103. PubMed ID: 12815165
[TBL] [Abstract][Full Text] [Related]
17. Structure activity studies of the melanocortin-4 receptor by in vitro mutagenesis: identification of agouti-related protein (AGRP), melanocortin agonist and synthetic peptide antagonist interaction determinants.
Haskell-Luevano C; Cone RD; Monck EK; Wan YP
Biochemistry; 2001 May; 40(20):6164-79. PubMed ID: 11352754
[TBL] [Abstract][Full Text] [Related]
18. Structures of the agouti signaling protein.
McNulty JC; Jackson PJ; Thompson DA; Chai B; Gantz I; Barsh GS; Dawson PE; Millhauser GL
J Mol Biol; 2005 Mar; 346(4):1059-70. PubMed ID: 15701517
[TBL] [Abstract][Full Text] [Related]
19. Agouti antagonism of melanocortin binding and action in the B16F10 murine melanoma cell line.
Blanchard SG; Harris CO; Ittoop OR; Nichols JS; Parks DJ; Truesdale AT; Wilkison WO
Biochemistry; 1995 Aug; 34(33):10406-11. PubMed ID: 7544613
[TBL] [Abstract][Full Text] [Related]
20. Characterization of melanocortin receptor subtype expression in murine adipose tissues and in the 3T3-L1 cell line.
Boston BA; Cone RD
Endocrinology; 1996 May; 137(5):2043-50. PubMed ID: 8612546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
